Open Access
Issue
Med Sci (Paris)
Volume 35, Number 12, Décembre 2019
Anticorps monoclonaux en thérapeutique
Page(s) 1206 - 1207
Section Les acteurs de l’hexagone
DOI https://doi.org/10.1051/medsci/2019221
Published online 06 January 2020
  1. Pèlegrin A, Daguet A, Watier H , MAbImprove. mAbs. 2014;6:803–4. [CrossRef] [PubMed] [Google Scholar]
  2. Guillon-Munos A, Daguet A, Watier H , Antibody biosimilars: fears or opportunities? mAbs. 2014;6:805–9. [CrossRef] [PubMed] [Google Scholar]
  3. Bodier-Montagutelli E, Respaud R, Watier H, et al. , MAbdelivery: administration routes for antibody therapy Third LabEx MAbImprove industrial workshop, July 2, 2015 Tours, France. mAbs. 2017;9:579–85. [CrossRef] [PubMed] [Google Scholar]
  4. Martin C, Kizlik-Masson C, Pèlegrin A, et al., Antibody-drug conjugates: design and development for therapy and imaging in and beyond cancer, LabEx MAbImprove industrial workshop, July 27–28, 2017, Tours, France. mAbs. 2018;10:210–21. [CrossRef] [PubMed] [Google Scholar]
  5. Diebolder CA, Beurskens FJ, de Jong RN, et al. , Complement is activated by igg hexamers assembled at the cell surface. Science. 2014;343:1260–3. [Google Scholar]
  6. Ugurlar D, Howes SC, de Kreuk B-J, et al., Structures of C1-IgG1 provide insights into how danger pattern recognition activates complement. Science. 2018;359:794–7. [Google Scholar]
  7. Scapin G, Yang X, Prosise WW, et al., Structure of full-length human anti-PD1 therapeutic IgG4 antibody pembrolizumab. Nat Struct Mol Biol. 2015;22:953–8. [CrossRef] [PubMed] [Google Scholar]
  8. Ternant D, Arnoult C, Pugnière M, et al., IgG1 allotypes influence the pharmacokinetics of therapeutic monoclonal antibodies through FcRn binding. J Immunol. 2016;196:607–613. [CrossRef] [PubMed] [Google Scholar]
  9. Dalloneau E, Baroukh N, Mavridis K, et al., Downregulation of the neonatal Fc receptor expression in non-small cell lung cancer tissue is associated with a poor prognosis. Oncotarget. 2016;7:54415–29. [CrossRef] [PubMed] [Google Scholar]
  10. Pieper K, Tan J, Piccoli L, et al. , Public antibodies to malaria antigens generated by two LAIR1 insertion modalities. Nature. 2017;548:597–601. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.